Ari Shomair
Corporate Officer/Principal at POINT Biopharma, Inc. (United States)
Ari Shomair active positions
| Companies | Position | Start | End |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - | - |
Career history of Ari Shomair
Former positions of Ari Shomair
| Companies | Position | Start | End |
|---|---|---|---|
| POIT BIOP | Human Resources Officer | - | 2023-12-26 |
| Public Communications Contact | - | - |
Statistics
International
| United States | 3 |
Operational
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Private companies | 1 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Stock Market
- Insiders
- Ari Shomair
- Experience
